top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjcvp

[...]our presence in MEDLINE will increase the visibility of, and interest for, the journal. [...]the editors and editorial board members feel very satisfied and confident for the future of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/10/2016 Item size : 112617 bytes
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Ehjournal

Conclusion In patients with a recent acute coronary syndrome, the addition of a new oral anticoagulant to antiplatelet therapy results in a modest reduction in cardiovascular events but a substantial ...

European Heart Journal, Oldgren, Jonas, Wallentin, Lars, Alexander, John H., James, Stefan, Jönelid, Birgitta, Steg, Gabriel, Sundström, Johan

Date : 07/06/2013
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Ehjournal

Conclusion In patients with a recent acute coronary syndrome, the addition of a new oral anticoagulant to antiplatelet therapy results in a modest reduction in cardiovascular events but a substantial ...

European Heart Journal, Oldgren, Jonas, Wallentin, Lars, Alexander, John H., James, Stefan, Jönelid, Birgitta, Steg, Gabriel, Sundström, Johan

Date : 07/06/2013 Item size : 311326 bytes
Ehjournal

On the cutting edge of acute coronary syndromes: adding oral factor Xa-inhibition with darexaban to dual antiplatelet therapy: the RUBY-1 trial In the era prior to acute percutaneous coronary ...

European Heart Journal, Kristensen, Steen D.

Date : 01/10/2011 Item size : 148759 bytes
Escardio

[...]the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) also found a consistently greater risk of haemorrhage in the 24-month dual therapy ...

Date : 30/08/2011
Escardio

EMBARGO : 31 August 2015 at 14:30 BST “Coronary artery disease and acute coronary syndromes are the cause of death and disability in many patients,” said Dr Raban Jeger, interventional ...

Date : 31/08/2015
Ehjournal

The recommended duration of 1year of dual antiplatelet therapy (DAPT) after an ACS is arbitrarily based on the treatment duration in the Clopidogrel in Unstable Angina to Prevent Recurrent Events ...

European Heart Journal, Sinnaeve, Peter R., Van de Werf, Frans

Date : 01/11/2017 Item size : 168596 bytes
Ehjournal

[...]renal function, haemodynamic variables, and signs of heart failure on admission are key components of the GRACE (Global Registry of Acute Coronary Events) score, which predicts mortality and ...

European Heart Journal, Wollert, Kai C.

Date : 21/04/2016 Item size : 199936 bytes